Bleeding News and Research

RSS

Mayo Clinic Women's HealthSource offers tips to reduce gas

Passing gas -- flatulence -- is normal and happens to everyone. But for some people, excessive gas and pain interfere with normal activities. The November issue of Mayo Clinic Women's HealthSource offers tips to reduce gas.

24 Nov 2009

Lysteda tablets to treat menorrhagia approved by the FDA

The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot.

24 Nov 2009

Opinion: China forced abortions; U.S. work in Africa; foreign aid; Uganda legislation

"One of the few incontrovertible assertions one can reasonably make is that no one supports forced abortion," syndicated columnist Kathleen Parker writes in a Detroit News opinion piece that examines reports of "coerced abortions" and involuntary sterilizations in China.

23 Nov 2009

UAB performs complicated eye reconstruction surgery

Singh and the team were practicing in Bundi, in northwestern India. It was a common drill, the coach hitting a golf ball at Singh, trying to keep the ball low. A field hockey ball is about the size of a baseball, and by trying to stop the much smaller and faster moving golf ball, it was thought a goalie could improve his reflexes and timing. Only this time the coach hit the ball too high.

21 Nov 2009

Twenty-five design teams compete in Brown School of Engineering Elevator Pitch Contest

Twenty-five Senior Design Teams competed for prizes Thursday night at Rice University's Brown School of Engineering Elevator Pitch Contest. The purpose of the contest was to get students to think about the commercial viability of their designs before building prototypes. Teams had 60 seconds to pitch their design project to an audience of local venture capitalists and business leaders.

20 Nov 2009

"Micro-endoscopes" to detect tumors at earlier stages being developed

Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection.

19 Nov 2009

Study: EP4 agonist may reduce gastric bleeding and inflammation

Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding.

19 Nov 2009

Medspira to manufacture and market Mayo Clinic developed products and technologies

Medspira, and Mayo Clinic have entered into an agreement to commercialize, manufacture and market several Mayo Clinic developed products and technologies invented by Mayo physicians and scientists.

19 Nov 2009

Drug interaction between clopidogrel and omeprazole: New safety information

Today the FDA notified healthcare professionals of new safety information concerning a drug interaction between clopidogrel, an anti-clotting medication, and omeprazole, a proton pump inhibitor (PPI) used to reduce stomach acid.

18 Nov 2009

Uniformly structured radiological test result reporting decreases the accuracy of the reports

As many software companies work to create programs that will give uniform structure to the way radiological test results are reported, a new study by researchers at Wake Forest University School of Medicine shows that such a system does not improve, but rather decreases the completeness and accuracy of the reports.

17 Nov 2009

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

17 Nov 2009

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.

17 Nov 2009

FDA approves Lysteda for treating menorrhagia

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.

16 Nov 2009

Self-care tips for hemorrhoids from Mayo Clinic

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem.

16 Nov 2009

Lack of hemophilia treatment in the developing world costing lives

When modern medicine finds a way to treat a medical condition, people often think that the problem is solved. But we also have to find ways to get that treatment into the hands of those who need it. For example, new research from North Carolina State University shows that much more needs to be done to help get existing treatment to hemophilia patients in the developing world, and that the current lack of treatment there is costing lives.

16 Nov 2009

FDA provides marketing clearance for the Platelet PGD Test System

The U.S. Food and Drug Administration today cleared for marketing the Platelet PGD Test System, the first rapid test for the detection of bacterial contamination in pooled platelets derived from whole blood.

16 Nov 2009

New reversible blood thinner for angioplasty patients not superior over placebo

A new reversible blood thinner for angioplasty patients wasn't superior over placebo for its primary combined endpoint of heart attack, all-cause mortality and need for revascularization, but it reduced mortality and in-stent blood clots, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

Amorfix Life Sciences, a company focused on misfolded protein diseases, today reported its second quarter operating results and provided an update on the Company's diagnostic and therapeutic programs.

13 Nov 2009

NJIT's EDC companies receive $1.4M funding from the New Jersey Commission on Science and Technology

A drug to stop bleeding during a brain injury and a mattress that will prevent bedsores are among the scientific discoveries at NJIT that received earlier this week more than a million dollars in funding from the New Jersey Commission on Science and Technology. The discoveries are the work of five early stage companies based at NJIT's Enterprise Development Center (EDC), the state's oldest business incubator program.

13 Nov 2009

Bleeding News and Research

Mayo Clinic Women's HealthSource offers tips to reduce gas

Lysteda tablets to treat menorrhagia approved by the FDA

Opinion: China forced abortions; U.S. work in Africa; foreign aid; Uganda legislation

UAB performs complicated eye reconstruction surgery

Twenty-five design teams compete in Brown School of Engineering Elevator Pitch Contest

"Micro-endoscopes" to detect tumors at earlier stages being developed

Study: EP4 agonist may reduce gastric bleeding and inflammation

Medspira to manufacture and market Mayo Clinic developed products and technologies

Drug interaction between clopidogrel and omeprazole: New safety information

Uniformly structured radiological test result reporting decreases the accuracy of the reports

New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

FDA approves Lysteda for treating menorrhagia

Self-care tips for hemorrhoids from Mayo Clinic

Lack of hemophilia treatment in the developing world costing lives

FDA provides marketing clearance for the Platelet PGD Test System

New reversible blood thinner for angioplasty patients not superior over placebo

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

Amorfix Life Sciences reports operating results for the three months ended September 30, 2009

NJIT's EDC companies receive $1.4M funding from the New Jersey Commission on Science and Technology

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News